GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zymeworks Inc (FRA:ZA8) » Definitions » Other Current Liabilities

Zymeworks (FRA:ZA8) Other Current Liabilities : €3.13 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zymeworks Other Current Liabilities?

Zymeworks's other current liabilities for the quarter that ended in Mar. 2024 was €3.13 Mil.

Zymeworks's quarterly other current liabilities increased from Sep. 2023 (€6.63 Mil) to Dec. 2023 (€7.96 Mil) but then declined from Dec. 2023 (€7.96 Mil) to Mar. 2024 (€3.13 Mil).

Zymeworks's annual other current liabilities increased from Dec. 2021 (€9.82 Mil) to Dec. 2022 (€15.11 Mil) but then declined from Dec. 2022 (€15.11 Mil) to Dec. 2023 (€7.96 Mil).


Zymeworks Other Current Liabilities Historical Data

The historical data trend for Zymeworks's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymeworks Other Current Liabilities Chart

Zymeworks Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zymeworks Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Zymeworks Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Zymeworks Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Zymeworks's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Zymeworks (FRA:ZA8) Business Description

Industry
Traded in Other Exchanges
Address
108 Patriot Drive, Suite A, Middletown, DE, USA, 19709
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Zymeworks (FRA:ZA8) Headlines

No Headlines